JOYN Advisors’s ANI Pharmaceuticals ANIP Stock Holding History

JOYN Advisors’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-15	Closed	-$1K	–	1745
2018 Q3	$1K	Sell	15 -3	-17%	-$184	﹤0.01%	1560
2018 Q2	$1K	Buy	+18	New	+$1.12K	﹤0.01%	1518

Other funds holding ANIP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return

ICOM

Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

JOYN Advisors's ANIP Position: Q4 2018 in Review

JOYN Advisors sold out of ANI Pharmaceuticals (ANIP) in Q4 2018, closing a stake of 15 shares — an estimated $1K sold.

JOYN Advisors first reported a position in ANIP in Q2 2018 and held it in 2 quarters. The position peaked at $1K in Q3 2018. 170 funds tracked by Wall St. Rank hold ANIP as of Q4 2018.

JOYN Advisors reported no remaining ANI Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
JOYN Advisors sold 15 ANI Pharmaceuticals shares in Q4 2018, an estimated $1K.
JOYN Advisors first reported a position in ANI Pharmaceuticals in Q2 2018 and held it in 2 quarters.
JOYN Advisors's ANI Pharmaceuticals position peaked at $1K in Q3 2018.
170 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q4 2018.

Based on JOYN Advisors's 13F filing for Q4 2018, filed 12 Feb 2019.